| Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II I Akhrymuk, SV Kulemzin, EI Frolova Journal of virology 86 (13), 7180-7191, 2012 | 244 | 2012 |
| COVID-19. Aetiology, pathogenesis, diagnosis and treatment VP Baklaushev, SV Kulemzin, АА Gorchakov, VN Lesnyak, ... Journal of Clinical Practice 11 (1), 7-20, 2020 | 75 | 2020 |
| Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer AA Gorchakov, SV Kulemzin, GV Kochneva, AV Taranin European urology 77 (3), 299-308, 2020 | 44 | 2020 |
| FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ... International immunology 23 (1), 43-53, 2011 | 42 | 2011 |
| Engineering chimeric antigen receptors SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin Acta Naturae (англоязычная версия) 9 (1 (32)), 6-14, 2017 | 29 | 2017 |
| Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ... Cell Discovery 7 (1), 96, 2021 | 26 | 2021 |
| VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ... Oncotarget 9 (10), 9021, 2018 | 25 | 2018 |
| Memory B cells induced by Sputnik V vaccination produce SARS-CoV-2 neutralizing antibodies upon ex vivo restimulation MG Byazrova, SV Kulemzin, EA Astakhova, TN Belovezhets, GA Efimov, ... Frontiers in Immunology 13, 840707, 2022 | 22 | 2022 |
| Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ... BMC medical genomics 12, 87-95, 2019 | 22 | 2019 |
| FCRL6 receptor: Expression and associated proteins SV Kulemzin, AY Zamoshnikova, MY Yurchenko, NY Vitak, AM Najakshin, ... Immunology letters 134 (2), 174-182, 2011 | 21 | 2011 |
| Strategies to circumvent the side-effects of immunotherapy using allogeneic CAR-T cells and boost its efficacy: Results of recent clinical trials S Smirnov, A Petukhov, K Levchuk, S Kulemzin, A Staliarova, K Lepik, ... Frontiers in Immunology 12, 780145, 2021 | 15 | 2021 |
| shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells VG Subrakova, SV Kulemzin, TN Belovezhets, AN Chikaev, NA Chikaev, ... Vavilov Journal of Genetics and Breeding 24 (1), 80, 2020 | 14 | 2020 |
| Combination of oncolytic virotherapy and car t/nk cell therapy for the treatment of cancer GV Kochneva, GF Sivolobova, AV Tkacheva, AA Gorchakov, SV Kulemzin Molecular Biology 54, 1-12, 2020 | 13 | 2020 |
| CAR T-cell therapy: Balance of efficacy and safety SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin, AA Gorchakov Molecular Biology 51, 237-250, 2017 | 10 | 2017 |
| Diversity of immunoglobulin light chain genes in non-teleost ray-finned fish uncovers IgL subdivision into five ancient isotypes SV Guselnikov, KO Baranov, AM Najakshin, LV Mechetina, NA Chikaev, ... Frontiers in Immunology 9, 2018 | 9 | 2018 |
| Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination EA Astakhova, MG Byazrova, GM Yusubalieva, SV Kulemzin, ... Cells 11 (13), 1991, 2022 | 8 | 2022 |
| Characterization of human FCRLA isoforms S Kulemzin, N Chikaev, O Volkova, E Reshetnikova, A Taranin, ... Immunology letters 152 (2), 153-158, 2013 | 8 | 2013 |
| Modular lentiviral vector system for chimeric antigen receptor design optimization SV Kulemzin, NA Chikaev, OY Volkova, VV Kuznetsova, AV Taranin, ... Russian Journal of Bioorganic Chemistry 43, 107-114, 2017 | 7 | 2017 |
| Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9 O Volkova, S Guselnikov, L Mechetina, N Chikaev, K Baranov, ... Monoclonal antibodies in immunodiagnosis and immunotherapy 33 (4), 209-214, 2014 | 7 | 2014 |
| Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ... Cell Ther. Transplant. 7, 70-76, 2018 | 5 | 2018 |
